Suchergebnisse - "Gulick, Roy M"

PubPharm (24)

1

Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events

enthalten in: Pharmacogenetics and genomics | 2018

von Haas, D. | Bradford, Y. | Verma, A. | +9

2

Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials Participants

enthalten in: The Journal of infectious diseases | 2017

von Mollan, K. | Tierney, C. | Hellwege, J. | +13

3

Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols

enthalten in: Pharmacogenetics and genomics | 2015

von Lehmann, D. | Ribaudo, H. | Daar, E. | +6

4

Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide : an analysis of trial data

enthalten in: Annals of internal medicine | 2014

von Mollan, K. | Smurzynski, M. | Eron, J. | +8

ErratumIn: Ann Intern Med. 2014 Aug 19;161(4):308

5

Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants

enthalten in: Pharmacogenetics and genomics | 2012

von Holzinger, E. | Grady, B. | Ritchie, M. | +9

6

Change in high-sensitivity c-reactive protein levels following initiation of efavirenz-based antiretroviral regimens in HIV-infected individuals

enthalten in: AIDS research and human retroviruses | 2011

von Shikuma, C. | Ribaudo, H. | Zheng, Y. | +7

7

Use of biological knowledge to inform the analysis of gene-gene interactions involved in modulating virologic failure with efavirenz-containing treatment regimens in ART-naïve ACTG clinical trials participants

enthalten in: Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing | 2011

von Grady, B. | Torstenson, E. | McLaren, P. | +7

8

Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response : an AIDS Clinical Trials Group study

enthalten in: The Journal of infectious diseases | 2010

von Ribaudo, H. | Liu, H. | Schwab, M. | +11

9

Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure

enthalten in: The Journal of infectious diseases | 2010

von Paredes, R. | Lalama, C. | Ribaudo, H. | +10

CommentIn: J Infect Dis. 2010 Mar;201(5):647-9. - PMID 20102273

10

Substitution of nevirapine because of efavirenz toxicity in AIDS clinical trials group A5095

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2010

von Schouten, J. | Krambrink, A. | Ribaudo, H. | +5

CommentIn: Clin Infect Dis. 2010 Aug 1;51(3):365; author reply 365-6. - PMID 20578877